These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 2075783

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Decreased insulin secretory capacity and normal pancreatic B-cell glucose sensitivity in non-obese patients with NIDDM.
    Van Haeften TW, Van Maarschalkerweerd WW, Gerich JE, Van der Veen EA.
    Eur J Clin Invest; 1991 Apr; 21(2):168-74. PubMed ID: 1905629
    [Abstract] [Full Text] [Related]

  • 4. Day-long integrated serum insulin and C-peptide profiles in patients with NIDDM. Correlation with urinary C-peptide excretion.
    Garvey WT, Olefsky JM, Rubenstein AH, Kolterman OG.
    Diabetes; 1988 May; 37(5):590-9. PubMed ID: 3282946
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Glucagon-like peptide 1 improves the ability of the beta-cell to sense and respond to glucose in subjects with impaired glucose tolerance.
    Byrne MM, Gliem K, Wank U, Arnold R, Katschinski M, Polonsky KS, Göke B.
    Diabetes; 1998 Aug; 47(8):1259-65. PubMed ID: 9703326
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of increased plasma non-esterified fatty acids (NEFAs) on arginine-stimulated insulin secretion in obese humans.
    Carpentier A, Giacca A, Lewis GF.
    Diabetologia; 2001 Nov; 44(11):1989-97. PubMed ID: 11719829
    [Abstract] [Full Text] [Related]

  • 11. Differential effects of ambient blood glucose level and degree of obesity on basal serum C-peptide level and the C-peptide response to glucose and glucagon in non-insulin-dependent diabetes mellitus.
    Park SW, Ihm SH, Yoo HJ, Park JY, Lee KU.
    Diabetes Res Clin Pract; 1997 Sep; 37(3):165-71. PubMed ID: 9306037
    [Abstract] [Full Text] [Related]

  • 12. First-phase insulin response to glucose in nonobese or obese subjects with glucose intolerance: analysis by C-peptide secretion rate.
    Kanatsuka A, Makino H, Sakurada M, Hashimoto N, Iwaoka H, Yamaguchi T, Taira M, Yoshida S, Yoshida A.
    Metabolism; 1988 Sep; 37(9):878-84. PubMed ID: 3047522
    [Abstract] [Full Text] [Related]

  • 13. Modulation of insulin secretion by insulin and glucose in type II diabetes mellitus.
    Garvey WT, Revers RR, Kolterman OG, Rubenstein AH, Olefsky JM.
    J Clin Endocrinol Metab; 1985 Mar; 60(3):559-68. PubMed ID: 3882736
    [Abstract] [Full Text] [Related]

  • 14. Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus.
    Vaag A, Henriksen JE, Madsbad S, Holm N, Beck-Nielsen H.
    J Clin Invest; 1995 Feb; 95(2):690-8. PubMed ID: 7860750
    [Abstract] [Full Text] [Related]

  • 15. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T, Krarup T, Sonne J, Madsbad S, Vølund A, Juul AG, Holst JJ.
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [Abstract] [Full Text] [Related]

  • 16. Clinical phenotypes, insulin secretion, and insulin sensitivity in kindreds with maternally inherited diabetes and deafness due to mitochondrial tRNALeu(UUR) gene mutation.
    Velho G, Byrne MM, Clément K, Sturis J, Pueyo ME, Blanché H, Vionnet N, Fiet J, Passa P, Robert JJ, Polonsky KS, Froguel P.
    Diabetes; 1996 Apr; 45(4):478-87. PubMed ID: 8603770
    [Abstract] [Full Text] [Related]

  • 17. Islet dysfunction in obese women with impaired glucose tolerance.
    Larsson H, Ahrén B.
    Metabolism; 1996 Apr; 45(4):502-9. PubMed ID: 8609839
    [Abstract] [Full Text] [Related]

  • 18. Insulin-induced hexokinase II expression is reduced in obesity and NIDDM.
    Pendergrass M, Koval J, Vogt C, Yki-Jarvinen H, Iozzo P, Pipek R, Ardehali H, Printz R, Granner D, DeFronzo RA, Mandarino LJ.
    Diabetes; 1998 Mar; 47(3):387-94. PubMed ID: 9519744
    [Abstract] [Full Text] [Related]

  • 19. Secretion and hepatic extraction of insulin after weight loss in obese noninsulin-dependent diabetes mellitus.
    Henry RR, Brechtel G, Griver K.
    J Clin Endocrinol Metab; 1988 May; 66(5):979-86. PubMed ID: 3283164
    [Abstract] [Full Text] [Related]

  • 20. [Primary study on characteristics of insulin secretion rate, metabolic clearance rate and sensitivity in non-insulin-dependent diabetic subjects from multiplex diabetic pedigrees].
    Ran J, Cheng H, Li F.
    Zhonghua Yi Xue Za Zhi; 2000 Jan; 80(1):38-41. PubMed ID: 11798736
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.